These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 35842679)

  • 81. Risk assessment model for overall survival in patients with locally advanced cervical cancer treated with definitive concurrent chemoradiotherapy.
    Shim SH; Lee SW; Park JY; Kim YS; Kim DY; Kim JH; Kim YM; Kim YT; Nam JH
    Gynecol Oncol; 2013 Jan; 128(1):54-59. PubMed ID: 23063760
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Radiomics Features of Multiparametric MRI as Novel Prognostic Factors in Advanced Nasopharyngeal Carcinoma.
    Zhang B; Tian J; Dong D; Gu D; Dong Y; Zhang L; Lian Z; Liu J; Luo X; Pei S; Mo X; Huang W; Ouyang F; Guo B; Liang L; Chen W; Liang C; Zhang S
    Clin Cancer Res; 2017 Aug; 23(15):4259-4269. PubMed ID: 28280088
    [No Abstract]   [Full Text] [Related]  

  • 83. Whole lesion histogram analysis of apparent diffusion coefficients on MRI predicts disease-free survival in locally advanced squamous cell cervical cancer after radical chemo-radiotherapy.
    Zhao B; Cao K; Li XT; Zhu HT; Sun YS
    BMC Cancer; 2019 Nov; 19(1):1115. PubMed ID: 31729974
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Preoperative prediction of cervical cancer survival using a high-resolution MRI-based radiomics nomogram.
    Li J; Zhou H; Lu X; Wang Y; Pang H; Cesar D; Liu A; Zhou P
    BMC Med Imaging; 2023 Oct; 23(1):153. PubMed ID: 37821840
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Model integrating CT-based radiomics and genomics for survival prediction in esophageal cancer patients receiving definitive chemoradiotherapy.
    Cui J; Li L; Liu N; Hou W; Dong Y; Yang F; Zhu S; Li J; Yuan S
    Biomark Res; 2023 Apr; 11(1):44. PubMed ID: 37095586
    [TBL] [Abstract][Full Text] [Related]  

  • 86. A Novel Multimodal Radiomics Model for Predicting Prognosis of Resected Hepatocellular Carcinoma.
    He Y; Hu B; Zhu C; Xu W; Ge Y; Hao X; Dong B; Chen X; Dong Q; Zhou X
    Front Oncol; 2022; 12():745258. PubMed ID: 35321432
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Prediction of Locoregional Recurrence-Free Survival of Oesophageal Squamous Cell Carcinoma After Chemoradiotherapy Based on an Enhanced CT-Based Radiomics Model.
    Kong J; Zhu S; Shi G; Liu Z; Zhang J; Ren J
    Front Oncol; 2021; 11():739933. PubMed ID: 34631575
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Radiomics signature for dynamic changes of tumor-infiltrating CD8+ T cells and macrophages in cervical cancer during chemoradiotherapy.
    Huang K; Huang X; Zeng C; Wang S; Zhan Y; Cai Q; Peng G; Yang Z; Zhou L; Chen J; Chen C
    Cancer Imaging; 2024 Apr; 24(1):54. PubMed ID: 38654284
    [TBL] [Abstract][Full Text] [Related]  

  • 89.
    Xu X; Sun X; Ma L; Zhang H; Ji W; Xia X; Lan X
    Front Oncol; 2023; 13():1149791. PubMed ID: 36969043
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Radiomics signature extracted from diffusion-weighted magnetic resonance imaging predicts outcomes in osteosarcoma.
    Zhao S; Su Y; Duan J; Qiu Q; Ge X; Wang A; Yin Y
    J Bone Oncol; 2019 Dec; 19():100263. PubMed ID: 31667064
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Cone-beam computed-tomography-based delta-radiomic analysis for investigating prognostic power for esophageal squamous cell cancer patients undergoing concurrent chemoradiotherapy.
    Nakamoto T; Yamashita H; Jinnouchi H; Nawa K; Imae T; Takenaka S; Aoki A; Ohta T; Ozaki S; Nozawa Y; Nakagawa K
    Phys Med; 2024 Jan; 117():103182. PubMed ID: 38086310
    [TBL] [Abstract][Full Text] [Related]  

  • 92. CT-based radiomics combined with hematologic parameters for survival prediction in locally advanced esophageal cancer patients receiving definitive chemoradiotherapy.
    Cui J; Zhang D; Gao Y; Duan J; Wang L; Li L; Yuan S
    Insights Imaging; 2024 Mar; 15(1):87. PubMed ID: 38523188
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Nomograms for predicting prognostic value of combined neutrophil-to-lymphocyte ratio and SCC-Ag in locally advanced cervical cancer.
    Jin L; Cao F; Zhang Y; Dang Y; Wang F
    Transl Cancer Res; 2024 Mar; 13(3):1323-1335. PubMed ID: 38617514
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Nomograms combining computed tomography-based body composition changes with clinical prognostic factors to predict survival in locally advanced cervical cancer patients.
    Fu B; Wei L; Wang C; Xiong B; Bo J; Jiang X; Zhang Y; Jia H; Dong J
    J Xray Sci Technol; 2024; 32(2):427-441. PubMed ID: 38189735
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Value of blood oxygenation level-dependent MRI for predicting clinical outcomes in uterine cervical cancer treated with concurrent chemoradiotherapy.
    Lee J; Kim CK; Gu KW; Park W
    Eur Radiol; 2019 Nov; 29(11):6256-6265. PubMed ID: 31016443
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Radiomics-based prediction of two-year clinical outcome in locally advanced cervical cancer patients undergoing neoadjuvant chemoradiotherapy.
    Autorino R; Gui B; Panza G; Boldrini L; Cusumano D; Russo L; Nardangeli A; Persiani S; Campitelli M; Ferrandina G; Macchia G; Valentini V; Gambacorta MA; Manfredi R
    Radiol Med; 2022 May; 127(5):498-506. PubMed ID: 35325372
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Pre-treatment MRI minimum apparent diffusion coefficient value is a potential prognostic imaging biomarker in cervical cancer patients treated with definitive chemoradiation.
    Marconi DG; Fregnani JH; Rossini RR; Netto AK; Lucchesi FR; Tsunoda AT; Kamrava M
    BMC Cancer; 2016 Jul; 16():556. PubMed ID: 27469349
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Comparing deep learning and handcrafted radiomics to predict chemoradiotherapy response for locally advanced cervical cancer using pretreatment MRI.
    Jeong S; Yu H; Park SH; Woo D; Lee SJ; Chong GO; Han HS; Kim JC
    Sci Rep; 2024 Jan; 14(1):1180. PubMed ID: 38216687
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Delta-radiomics signature predicts treatment outcomes after preoperative chemoradiotherapy and surgery in rectal cancer.
    Jeon SH; Song C; Chie EK; Kim B; Kim YH; Chang W; Lee YJ; Chung JH; Chung JB; Lee KW; Kang SB; Kim JS
    Radiat Oncol; 2019 Mar; 14(1):43. PubMed ID: 30866965
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Comparing survival outcomes between surgical and radiographic lymph node assessment in locally advanced cervical cancer: A propensity score-matched analysis.
    Yang J; Delara R; Magrina J; Magtibay P; Yi J; Langstraat C; Robertson M; Dinh T; Butler K
    Gynecol Oncol; 2020 Feb; 156(2):320-327. PubMed ID: 31843274
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.